2011
DOI: 10.1016/j.neuint.2011.06.012
|View full text |Cite
|
Sign up to set email alerts
|

The influence and the mechanism of docosahexaenoic acid on a mouse model of Parkinson’s disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
29
0
1

Year Published

2014
2014
2024
2024

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 50 publications
(30 citation statements)
references
References 86 publications
0
29
0
1
Order By: Relevance
“…Many reports have shown that treatments based on omega 3 fatty acids exert beneficial effects in various animal models of neurodegenerative disease, such as Parkinson's or Alzheimer's diseases (Arsenault et al, 2011; Ozsoy et al, 2011). In a recent study, Michael-Titus and colleagues investigated the neuroprotective effect of eicosapentaenoic acid, an omega 3 fatty acid precursor for DHA, in SOD1 mice.…”
Section: A Role For Lipids Beside Energetic Metabolismmentioning
confidence: 99%
“…Many reports have shown that treatments based on omega 3 fatty acids exert beneficial effects in various animal models of neurodegenerative disease, such as Parkinson's or Alzheimer's diseases (Arsenault et al, 2011; Ozsoy et al, 2011). In a recent study, Michael-Titus and colleagues investigated the neuroprotective effect of eicosapentaenoic acid, an omega 3 fatty acid precursor for DHA, in SOD1 mice.…”
Section: A Role For Lipids Beside Energetic Metabolismmentioning
confidence: 99%
“…DHA protects neurons against cytotoxicity, inhibits nitrogen oxide (NO) production, and calcium (Ca 2+ ) influx. DHA enhances the activities of antioxidant enzymes such as glutathione peroxidase and glutathione reductase and diminishes apoptosis in dopaminergic cells [45] in the brains of mice post-MPTP treatment. Short-term administration of DHA markedly reduced levodopa-induced dyskinesias in parkinsonian primates and caused significant reduction in parkinsonian behaviors and elevated dopamine (DA) levels in 6-OHDA rodents [46].…”
Section: Omega-3 Polyunsaturated Fatty Acids (Pufas)mentioning
confidence: 99%
“…It may also have a benefit to PD animal models. Animals with MPTP-induced impaired balance and motor coordination showed diminished Parkinsonism symptoms and decreased dopaminergic neuronal death when fed a DHA diet (Ozsoy et al, 2011) DHA and EPA improve memory performance in mild AD (Scheltens et al, 2012;Yehuda et al, 1996) …”
Section: Small Molecules That Promote Protein Refoldingmentioning
confidence: 99%
“…Animals dosed with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP)-exhibited impaired balance and motor coordination, but diminished parkinsonism symptoms and decreased dopaminergic neuronal death when fed a DHA diet (Ozsoy et al, 2011). DHA supplementation may protect dopaminergic neurons in experimental PD models by targeting inflammatory signaling pathways and enhancing the expression of GDNF and Neurturin (member of the same protein family as glial cell-derived neurotrophic factor), which has been shown to benefit the dopaminergic neurons in the substantia nigra which is affected in PD (Bousquet et al, 2011;Cardoso et al, 2012;Hacioglu et al, 2012;Ji et al, 2012;Ozsoy et al, 2011;Tanriover et al, 2010). DHA supplementation in a nonhuman primate MPTP model reduces levodopa-induced dyskinesia, suggesting a safe and innovative therapy for improving the life quality of PD patients (Mahmoudi et al, 2009).…”
Section: Proteasome Activatorsmentioning
confidence: 99%